Skip to main content
Pharmicell Co.,Ltd. logo

Pharmicell Co.,Ltd. — Investor Relations & Filings

Ticker · 005690 ISIN · KR7005690003 KO Manufacturing
Open in API
Filings indexed 275 across all filing types
Latest filing 2022-12-26 Regulatory Filings
Country KR South Korea
Listing KO 005690

About Pharmicell Co.,Ltd.

https://www.pharmicell.com/eng/

Pharmicell Co., Ltd. is a biopharmaceutical company specializing in stem cell technology and advanced bio-based materials. The company is a pioneer in regenerative medicine, having developed Hearticellgram-AMI, the world's first approved stem cell therapy for acute myocardial infarction. Its core business includes the development of stem cell therapeutics, a stem cell banking service for adult and cord blood cells, and a line of cosmetics based on stem cell culture media. A significant division focuses on fine chemicals, manufacturing and supplying critical raw materials for the pharmaceutical industry, such as nucleosides, mPEGs, and oligonucleotides for gene therapies. The company also produces eco-friendly flame retardants for industrial use.

Recent filings

Filing Released Lang Actions
단일판매ㆍ공급계약체결
Regulatory Filings Classification · 100% confidence The document is a formal regulatory disclosure regarding a 'Single Sale/Supply Contract' (단일판매ㆍ공급계약체결) between Pharmicell and LG Chem. It details the contract amount, duration, and counterparty. Since this is a specific regulatory announcement of a business contract that does not fit into the other specialized categories like M&A or financial reports, it falls under the general regulatory filing category.
2022-12-26 Korean
기업설명회(IR)개최(안내공시)
Report Publication Announcement Classification · 100% confidence The document is a short announcement (under 1,000 characters) regarding the scheduling of an Investor Relations (IR) meeting. It provides the date, location, purpose, and method of the meeting, but does not contain the actual presentation slides or detailed financial data. According to the 'Menu vs Meal' rule, an announcement of an event or report is classified as a Report Publication Announcement (RPA) or a general regulatory filing. Given the specific nature of the announcement regarding an upcoming corporate event, it fits best as a Regulatory Filing (RNS) or an announcement of an event.
2022-11-21 Korean
분기보고서 (2022.09)
Interim / Quarterly Report Classification · 100% confidence The document is a '분기보고서' (Quarterly Report) for Pharmicell Co., Ltd. covering the period from January 1, 2022, to September 30, 2022. It contains detailed financial information, business operations, management discussion, and capital structure, which aligns with the definition of an Interim/Quarterly Report (IR). 9M 2022
2022-11-08 Korean
기업설명회(IR)개최(안내공시)
Report Publication Announcement Classification · 100% confidence The document is a short announcement (637 characters) regarding the scheduling of an Investor Relations (IR) meeting. It provides the date, location, purpose, and participants for an upcoming event. According to the 'Menu vs Meal' rule, an announcement of an event or report is classified as a Report Publication Announcement (RPA) or a general regulatory filing. Since it specifically announces the holding of an IR event, it fits best under the Report Publication Announcement (RPA) category as it serves as a notice for an upcoming corporate activity.
2022-10-21 Korean
임원ㆍ주요주주특정증권등소유상황보고서
Director's Dealing Classification · 100% confidence The document is a 'Report on Ownership of Specific Securities by Executives and Major Shareholders' (임원ㆍ주요주주 특정증권등 소유상황보고서) filed by an executive (Kim Hyun Soo) of Pharmicell Co., Ltd. This type of filing is a standard regulatory requirement for reporting insider transactions or changes in share ownership by company directors and executives. Based on the provided categories, this aligns with 'Director's Dealing' (DIRS), which covers personal share transactions by company directors and executives.
2022-10-17 Korean
주식등의대량보유상황보고서(일반)
Major Shareholding Notification Classification · 100% confidence The document is a '주식등의 대량보유상황보고서' (Report on Large Shareholding), which is a standard regulatory filing in South Korea under the Capital Markets Act. It details changes in share ownership by a major shareholder (Kim Hyun Soo) and special related parties, including the purpose of holding (influence on management) and specific transaction details (conversion of convertible bonds). This falls under the category of Major Shareholding Notification.
2022-10-17 Korean

Browse filings by year

9 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.